Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer

被引：0
作者：
Demosthenes Makris
Arnaud Scherpereel
Marie Christine Copin
Guillaume Colin
Luc Brun
Jean Jacques Lafitte
Charles Hugo Marquette
机构：
[1] CHRU of Lille,Pulmonary and Thoracic Oncology Department
[2] INSERM Unit 774,Pathology Department
[3] Institut Pasteur of Lille,Clinique des Maladies Respiratoires
[4] CHRU of Lille,undefined
[5] Hôpital Albert Calmette,undefined
[6] CHRU de Lille,undefined
来源：
BMC Cancer | / 7卷
关键词：
Docetaxel; Gemcitabine; Human Epidermal Growth Factor Receptor; Erlotinib; Interstitial Lung Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer
    Nasrallah, Haitam
    Bar-Sela, Gil
    Haim, Nissim
    MEDICAL ONCOLOGY, 2012, 29 (01) : 212 - 214
  • [2] Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer
    Haitam Nasrallah
    Gil Bar-Sela
    Nissim Haim
    Medical Oncology, 2012, 29 : 212 - 214
  • [3] Fatal Asymmetric Interstitial Lung Disease after Erlotinib for Lung Cancer
    Ren, Shaohua
    Li, Yuan
    Li, Weiwen
    Zhao, Zhongwei
    Jin, Chunxian
    Zhang, Dengke
    RESPIRATION, 2012, 84 (05) : 431 - 435
  • [4] Fatal interstitial lung disease after erlotinib administration in a patient with radiation fibrosis
    Um, Soo-Jung
    Lee, Soo-Keol
    Yang, Doo Kyung
    Son, Choonhee
    Roh, Mee Sook
    Kim, Ki Nam
    Lee, Ki-Nam
    Choi, Pil Jo
    CLINICAL RESPIRATORY JOURNAL, 2009, 3 (03) : 181 - 184
  • [5] Fatal interstitial lung disease associated with high erlotinib and metabolite levels. A case report and a review of the literature
    ter Heine, R.
    van den Bosch, R. T. A.
    Schaefer-Prokop, C. M.
    Lankheet, N. A. G.
    Beijnen, J. H.
    Staaks, G. H. A.
    van der Westerlaken, M. M.
    Malingre, M. M.
    van den Brand, J. J. G.
    LUNG CANCER, 2012, 75 (03) : 391 - 397
  • [6] Fatal interstitial lung disease associated with icotinib
    Zhang, Jiexia
    Zhan, Yangqing
    Ouyang, Ming
    Qin, Yinyin
    Zhou, Chengzhi
    Chen, Rongchang
    JOURNAL OF THORACIC DISEASE, 2014, 6 (12) : E267 - E271
  • [7] Fatal interstitial lung disease associated with AZD9291
    Deng, Sheng-ming
    Huang, Jian-an
    Chen, Yan-bin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S1227 - S1229
  • [8] Fatal Interstitial Lung Disease after Addition of Sorafenib to a Patient with Lung Adenocarcinoma Who Had Failed to Improve with Erlotinib Alone
    Guan, Yin
    Meng, Jing
    Zhao, Hong
    Hu, Yi
    Yan, Xiang
    Zhao, Shao-Hong
    Jiao, Shun-Chang
    CASE REPORTS IN ONCOLOGY, 2014, 7 (01): : 273 - 276
  • [9] Erlotinib-associated interstitial lung disease in advanced pancreatic carcinoma: a case report and literature review
    Macerelli, Marianna
    Mazzer, Micol
    Foltran, Luisa
    Cardellino, Giovanni Gerardo
    Aprile, Giuseppe
    TUMORI JOURNAL, 2015, 101 (04): : E122 - E127
  • [10] Interstitial lung disease associated with drug therapy
    Camus, P
    Kudoh, S
    Ebina, M
    BRITISH JOURNAL OF CANCER, 2004, 91 (Suppl 2) : S18 - S23
12345